Company Description
Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury.
The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs and other shared health products; oxygen chambers and beauty instruments; and shampoo instruments and nano thermal therapy chambers.
It operates in the Mainland China, Japan, the United States, Hong Kong, Singapore, Korea, Australia, and internationally.
The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. operates as a subsidiary of Jolly Harmony Enterprises Limited.
| Country | China |
| Founded | 2006 |
| IPO Date | Mar 28, 2023 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 273 |
| CEO | Erqi Wang |
Contact Details
Address: No. 33 Lingxiang Road, Wujin District Changzhou China | |
| Phone | 86 51 9896 07972 |
| Website | zhjmedical.com |
Stock Details
| Ticker Symbol | ZJYL |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| IPO Price | $8.00 |
| CIK Code | 0001837821 |
| ISIN Number | KYG5140V1124 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Erqi Wang | Chairman of the Board, President and Chief Executive Officer |
| Ziqiang Wang | Chief Financial Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 10, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Feb 9, 2026 | 6-K | Report of foreign issuer |
| Feb 4, 2026 | 6-K | Report of foreign issuer |
| Jan 30, 2026 | NT 20-F | Notification of inability to timely file Form 20-F |
| Jan 28, 2026 | 6-K | Report of foreign issuer |
| Jan 22, 2026 | 6-K | Report of foreign issuer |
| Jan 21, 2026 | 6-K | Report of foreign issuer |
| Jan 8, 2026 | 6-K | Report of foreign issuer |
| Sep 9, 2025 | EFFECT | Notice of Effectiveness |
| Sep 3, 2025 | F-3/A | Filing |